Industry and Geographic Information (Tables)

9 Months Ended

Sep. 30, 2018

Industry And Geographic Information [Abstract]

Sales to Individual Customers in Excess of 10% of Total Revenues

The Company had sales to individual customers in excess of 10% of total revenues, as follows:

	Nine months ended   September 30,
	2018		2017
Customer:
A	17	%	21	%
B	14	%	13	%
C	12	%	21	%
	43	%	55	%

Net Revenues by Product Category

Consolidated net revenues by product category for the three and nine months ended September 30, 2018 and 2017 are as follows (in thousands):

	Three month ended September 30,				Nine months ended   September 30,
	2018		2017		2018		2017
Rapid Immunoassay	$	35,366	$	36,458	$	132,740	$	115,974
Cardiac Immunoassay	65,287		—		203,581		—
Specialized Diagnostic Solutions	12,294		11,655		39,859		37,731
Molecular Diagnostic Solutions	4,452		2,781		13,517		9,148
Total revenues	$	117,399	$	50,894	$	389,697	$	162,853